Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Forte Group Holdings Inc C.FGH

Alternate Symbol(s):  FGHFF

Forte Group Holdings Inc. is a diversified lifestyle and wellness consumer packaged goods company. The Company develops and manufactures a range of alkaline and mineral-enriched beverages and nutraceutical supplements for both its TRACE brand and private-label clients. It operates through two segments: alkaline and mineralized beverages and supplements and eCommerce. The alkaline and... see more

CSE:FGH - Post Discussion

Forte Group Holdings Inc > https://www.embarkhealthinc.com/news
View:
Post by shneps on Jan 26, 2022 8:16am

https://www.embarkhealthinc.com/news

Embark Health.
Healthy?
Reviewing Embark health's news releases you'll note that the company used to release news at a pretty good rate. Once a week and even multiple times a week but this all ended at the end of April 2021.
There has only been a single NR in nine months, that being the acquisition by Bevcanna.
You can't tell me that was a healthy active company.
The acquisition is not complete but you will note that Keefs products are being sold under the Embark licence, utilizing the Stigma Grow emulsions.
Comment by moneymachine88 on Jan 26, 2022 10:25am
Stigma grow does not do emulsions embark is their sales agent, as usual you post BS! instead of wasting so much time posting bullshit, maybe you want to get prepared, like find a good lawyer!
Comment by shneps on Jan 26, 2022 1:41pm
You are correct. Keefs was being sold under Stigma Grows sales licence with the Vertosa cannabis extract being produced by Vivo in Napanee.  Keefs is now being sold under the Embark licence with the plant still being grown in Napanee and extracted by Vivo for Vertosa. Apologies not always easy to remember who is sleeping with who.
Comment by shneps on Jan 26, 2022 2:00pm
https://hygrovest.com.au/2021/09/21/mmj-receives-an-offer-to-acquire-its-investment-in-embark-health/
Comment by shneps on Jan 26, 2022 5:55pm
So Moneymachine. What is your off take from that MMJ news release? Anything of importance to Bevcanna shareholders.
Comment by shneps on Jan 27, 2022 9:55am
Definitely some good info there. 1. Bevcanna was to issue 46.7M shares (doesn't include warrants and options) at a share price   of  $0.34. Now with market adjustments to the current share price (18c) that is now 116.7M      shares + (warrants and options). 2. Embark shares will be released on the last day of each month for the next twelve months.    ...more  
Comment by shneps on Jan 27, 2022 9:48am
Hygrovest ( formerly MMJ Holdings) has a $1.5M investment in Embark as well. " Embark Health: A$1.5 million. Hygrovest's investment will be acquired by listed BevCanna Enterprises Inc following shareholder approval in December 2021."
Comment by shneps on Jan 27, 2022 9:51am
The following pdf is far more important to take note of: https://hygrovest.com.au/wp-content/uploads/2022/01/2327896.pdf
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities